(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.32% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Avient's revenue in 2025 is $3,254,800,000.On average, 5 Wall Street analysts forecast AVNT's revenue for 2025 to be $300,360,162,223, with the lowest AVNT revenue forecast at $296,920,800,040, and the highest AVNT revenue forecast at $302,898,582,146. On average, 5 Wall Street analysts forecast AVNT's revenue for 2026 to be $311,718,790,398, with the lowest AVNT revenue forecast at $308,949,413,625, and the highest AVNT revenue forecast at $316,730,361,820.
In 2027, AVNT is forecast to generate $323,720,124,894 in revenue, with the lowest revenue forecast at $318,652,713,727 and the highest revenue forecast at $326,748,744,554.